Dr. Arjun Sahgal on a major advance for high-grade gliomas with adaptive online MR-guided radiation therapy

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/7e/0e/cc/7e0ecca1-071d-cc46-ab55-10df499acf81/mza_6894969959932481215.jpg/600x600bb.jpg

Spilling the RT

Elekta

6 episodes

4 days ago

Spilling the RT is a podcast series from Elekta that features conversations around radiation therapy with clinical experts who are changing the game in radiation oncology. Each episode explores exciting research, technology or emerging trends with leaders who are not just advancing the field, but passionate about making a difference. Plus, we get personal – discovering what drives these individuals and how their journeys began. Hosted and moderated by Elekta’s Global Clinical Communications Manager, Emily Basset, this series is your front-row seat to everything radiotherapy. Subscribe to Spilling the RT on Apple and Spotify or listen on Elekta’s YouTube channel.

All content for Spilling the RT is the property of Elekta and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Dr. Arjun Sahgal on a major advance for high-grade gliomas with adaptive online MR-guided radiation therapy

Spilling the RT

39 minutes

6 months ago

Dr. Arjun Sahgal on a major advance for high-grade gliomas with adaptive online MR-guided radiation therapy

In this episode, Dr. Arjun Sahgal, an international clinical and research leader in the field of high-precision stereotactic radiation to the brain and spine for both metastases and primary tumors, as well as oligometastases and the chief of radiation oncology at Sunnybrook Health Sciences Centre’s Odette Cancer Centre, shares his excitement around the initial results of the UNITED (Unity-Based MR-Linac Guided Adaptive Radiotherapy for High Grade Glioma) trial. UNITED is the world’s first adaptive MR-guided radiotherapy study for patients with high-grade gliomas, the most common and aggressive primary brain tumors found in adults, and the highlight of his illustrious career so far.

Dr. Sahgal has made challenging the dogma and changing the standard of care for patients whose cancer is considered “incurable” his trademark. But what inspires him? Tune in to episode 2 of Spilling the RT to find out.